Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PHVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PHVS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Pharvaris BV

PHVS
Current price
23.00 USD +0.08 USD (+0.35%)
Last closed 22.99 USD
ISIN NL00150005Y4
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 158 286 208 USD
Yield for 12 month +25.27 %
1Y
3Y
5Y
10Y
15Y
PHVS
21.11.2021 - 28.11.2021

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist for the treatment of attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), as well as in Phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland. Address: Grafenauweg 8, Zug, Switzerland, 6300

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

34.24 USD

P/E Ratio

Dividend Yield

Financials PHVS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PHVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-294 877 USD

Current Quarter

Last Quarter

EBITDA -159 490 880 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -31.88 %
PEG Ratio
Return On Equity TTM -52.20 %
Wall Street Target Price 34.24 USD
Revenue TTM
Book Value 4.14 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.30 USD
Diluted Eps TTM -3.30 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation PHVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.38
Price Book MRQ 3.81

Technical Indicators PHVS

For 52 Weeks

11.51 USD 25.76 USD
50 Day MA 17.17 USD
Shares Short Prior Month 784 870
200 Day MA 17.94 USD
Short Ratio 12.00
Shares Short 785 352
Short Percent 1.80 %